Misuse of Drugs Act 1971 (Amendment) Order 2012

My Lords, I apologise for my near lateness but I am here on time. I beg to move that the Committee considers the draft Misuse of Drugs Act 1971 (Amendment) Order 2012, which was laid before Parliament on 28 February. I will have problems with some of the pronunciations but this order will bring 2-DPMP and its related compounds—phenazepam and any ester or ether of pipradrol—under the control of the 1971 Act, based on the recommendations put forward by our independent experts, the Advisory Council on the Misuse of Drugs, following its assessment of all available evidence. The drugs subject to the order are so-called legal highs or new psychoactive substances which imitate the effects of and are chemically related to existing illegal drugs. I make three points. First, the ACMD likens the harms of 2-DPMP and its related compounds to controlled class B drugs which include amphetamines. We accept the ACMD's assessment of evidence that 2-DPMP and its related compounds, as defined by the generic definition which the ACMD has provided, are sufficiently harmful to warrant class B control under the 1971 Act. Secondly, the order makes a technical amendment to include any ester or ether of pipradrol not captured by the generic definition as class C drugs alongside the main drug pipradrol to which they are chemically related. This ensures that we are consistent with current definitions used in the 1971 Act. Thirdly, the order adds phenazepam, via its full chemical name, to the list of—I now have a very difficult one—benzodiazepines which are controlled class C drugs under the 1971 Act. The ACMD's advice highlights evidence that websites selling so-called legal highs have exploited the current position that phenazepam is not one of the benzodiazepines covered by the 1971 Act, while the harms indicate that it is one of the more potent benzodiazepines. This order, if it is made, will enable law enforcement agencies to take full steps to curtail the availability and misuse of these harmful psychoactive substances. There will be two negative instruments to complement this order. A designation order will be made to designate 2-DPMP and its related compounds under the generic definition, as they have no recognised medicinal or legitimate use. The designation order will amend the Misuse of Drugs (Designation) Order 2001. Regulations will also be made to amend the Misuse of Drugs Regulations 2001. It will include designated 2-DPMP and its related compounds in Schedule 1 to those regulations while phenazepam and esters or ethers of pipradrol will be placed with Schedule 3 drugs under the 2001 regulations to reflect their medical properties. These negative instruments will be prepared to come into force at the same time as the order. We will publicise these legislative changes through a Home Office circular addressed to all United Kingdom police forces and our criminal justice partners. I beg to move.